Ludwig, H; Kasparu, H; Linkesch, W; Thaler, J; Greil, R; Leitgeb, C; Heintel, D; Rauch, E; Zojer, N; Pour, L; Seebacher, A; Adam, Z.
Bortezomib-Bendamustine-Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (MM) Shows Marked Efficacy and Is Well Tolerated, but Assessment of PNP Symptoms Shows Significant Discrepancies Between Patients and Physicians
BLOOD. 2011; 118(21): 1262-1263.
[Poster]
Web of Science